Revance Therapeutics, Inc. Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Revance Therapeutics, Inc. (RVNC) – Deadline is March 4, 2025… Read MoreJoin Investigation
Carvana Co. Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Carvana Co. (“Carvana” or the “Company”) (NYSE: CVNA)…. Read MoreJoin Investigation
